Progression of VAS pain score at activity (physical therapy) throughout the immediate postoperative period. by Khushboo Baldev (12003956)

Baseline characteristics of the included studies. by Wenxuan Guo (3752632)

Variable sources of agar formulations have significant differences in stiffness. by Maria Oorloff (19658113)

Subjects:

Forest Plot of Objective Measure of reduction in UI Meta-Analysis. by Maureen O’ Callaghan (21368375)

Subjects:

Summary of included studies for outcome evaluation. by Tzu-Hsuan Yeh (2543161)

Subjects:

Univariate and multivariable analyses for progression free survival. by Huriye Senay Kiziltan (22298378)

Subjects:

Flow chart of the study participants including changes in exercise capacity (n = 198). by Feras Haskiah (14204097)

Subjects:

Characteristics of included randomized controlled trials. by Haidong Deng (8128269)

ROC curve analysis for ERCC1 with CWP progression. by Hao Deng (409186)

Factors associated with dose reduction of pirfenidone. by Jiwon Kim (573413)

Subjects:

Overview of included observational studies. by Karel H. van der Pol (11785133)

Includes all related data. by Savvas Stafilidis (7022657)

HPV16 E1 decreases cell growth. by Fern Baedyananda (11888703)

Proportion structure of carbon reduction methods. by Peijiong Feng (17020939)

Funnel plots of studies included in the meta-analysis assessing by Solima Sabeel (9545738)

Subjects:

Risk of bias graph across all included studies. by Jiawei Zheng (796506)

“…Subgroup analyses superimposed that incorporating NMES did not result in a meaningful reduction in pain intensity (MD: −0.85; 95% CI: −1.76 to 0.07; P = 0.07) or a significant improvement in quadriceps muscle strength (SMD: 0.27; 95% CI: −0.24 to 0.78; P = 0.30) when the treatment period was less than or equal to 4 weeks.…”

Quality of included studies based on the RoB 2. by Krisna Adiasto (12890049)

Subjects:

Characteristics of included studies and patients’ characteristics. by D. Douillet (6861836)

Including additional biomarker targets further narrows the predicted optimal diets. by Julia H. Chen (16745256)

Characterization of cardiac function, LV wall thickness, heart rate, LV mass and organ weight in non-symptomatic <i>Gla</i>KO Fabry mice and age-matched WT controls at 13 months of... by Abirami Kugadas (3131940)

Subjects: